Covadonga Pañeda

Dr. Pañeda has over 15 years of experience in drug development. She spent 7 years as R&D Manager at Sylentis S.A., a clinical stage RNAi biopharma company and most recently, she served as Director of Development at Limm Therapeutics, a neuroimmune biopharma company. Dr. Pañeda obtained a Ph.D. in Biochemistry and Molecular Biology at the Faculty of Medicine at Universidad Autónoma, Madrid, Spain, and spent several years as a Post-doc at the Scripps Research Institute, La Jolla, CA.